DIPLOMAT PHARMACY, INC.

DIPLOMAT PHARMACY, INC. is a Corporation (For-Profit) in NOVI, United States with 1 ISIN-identified security mapped to its LEI, which is how regulators tie a traded instrument to the issuer behind it.

The LEI has been on record for 12 years, since 21 Jan 2014. That is about 5 years earlier than the median LEI in United States, which dates from 2018 — an early adopter by local standards.

Annual re-validation is 2307 days overdue: it fell due 14 Apr 2020. An LEI that is not re-validated lapses, which does not invalidate it but marks the reference data as unverified.

The record has not changed since we began archiving it on 6 Jul 2026. Any future change to name, status, address, ownership or renewal date will be captured here, because GLEIF publishes only the current state and superseded values are otherwise lost.

The LEI is issued and maintained by Bloomberg Finance L.P., one of the Local Operating Units accredited by GLEIF.

Beyond the LEI, 1 ISIN is mapped to this entity in the GLEIF cross-reference files.

No direct accounting-consolidating parent is reported, because no controlling person is known. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because no controlling person is known. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is lapsed, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.